相关实验视频
Updated: Jun 23, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.4K
过度表达Malat1通过瘤微环境的炎症重编程驱动转移
Elena Martinez-Terroba1, Leah M Plasek-Hegde1, Ioannis Chiotakakos1
1Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, USA.
Science immunology
|June 14, 2024
概括
转移相关的肺腺癌转录1 (MALAT1) 通过重编程瘤微环境来驱动肺癌转移. 过度表达MALAT1会增加细胞流动性,并招募巨细胞,促进瘤的进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 长非编码RNA (lncRNA) 转移相关的肺腺癌转录1 (MALAT1) 与各种癌症的瘤进展和转移有关.
- 通过MALAT1促进转移性疾病的确切机制在很大程度上是未知的.
研究的目的:
- 研究MALAT1在驱动肺腺癌 (LUAD) 转移中的功能影响和潜在机制.
- 阐明MALAT1如何影响瘤微环境并促进癌症的进展.
主要方法:
- 使用CRISPR激活 (CRISPRa) 在患者衍生的LUAD细胞系和原生K-ras/p53 LUAD小鼠模型中过度表达MALAT1.
- 进行了细胞移动性测定,巨细胞招募分析和染色质可访问性的评估.
- 评估MALAT1过度表达的影响与巨细胞枯竭和CCL2阻塞结合.
主要成果:
- 在小鼠模型中,MALAT1的过度表达足以促进LUAD进展和转移.
- 马拉特1增强了癌细胞的移动性,并通过CCL2膜分泌促进了原始原始巨细胞的招募.
- CCL2上调是MALAT1.1诱导的全球染色质可访问性增加的结果.
- 抑制巨细胞或阻断CCL2有效抵消了MALAT1.1的转移前作用.
结论:
- 一个单一的lncRNA,MALAT1,可以通过重编程瘤微环境来驱动LUAD转移.
- MALAT1的机制涉及增强细胞运动性和通过CCL2信号招募促进瘤巨细胞.
- 准MALAT1或其下游效应器为LUAD转移提供了潜在的治疗策略.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K

